PolyPeptide Group AG (LON: 0AAJ)
London
· Delayed Price · Currency is GBP · Price in CHF 26.35
+0.35 (1.35%)
Jan 23, 2025, 8:08 AM BST
PolyPeptide Group AG Revenue
PolyPeptide Group AG had revenue of 135.04M EUR in the half year ending June 30, 2024, with 1.04% growth. This brings the company's revenue in the last twelve months to 323.58M, up 15.91% year-over-year. In the year 2023, PolyPeptide Group AG had annual revenue of 320.37M with 14.02% growth.
Revenue (ttm)
323.58M EUR
Revenue Growth
+15.91%
P/S Ratio
n/a
Revenue / Employee
254.19K EUR
Employees
1,273
Market Cap
765.80M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| GSK plc | 31.31B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| ConvaTec Group | 1.74B |
| Hikma Pharmaceuticals | 2.39B |
| HUTCHMED (China) | 483.31M |
| Oxford Nanopore Technologies | 167.75M |